Metraipolis › archive › dc_85a3c76def59

A Novel Inactivated Vaccine Based on an Emerging PEDV GIIc Variant Provides Cross-Protection Against Heterologous GII Strains — Europe PMC PMID:41746072

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41746072
DOI
10.3390/vaccines14020151
License (as archived)
solo-consultazione
Archived
2026-11-06T03:54:35.244Z
SHA-256 of the archived text
d794902ea37748ca5a8f06c9f089b6838684e976ad93b628caf6c573d961ad46
Stable URL of this page
https://metraipolis.com/documento/dc_85a3c76def59

How to cite

A Novel Inactivated Vaccine Based on an Emerging PEDV GIIc Variant Provides Cross-Protection Against Heterologous GII Strains — Europe PMC PMID:41746072 — Europe PMC (en), https://europepmc.org/article/MED/41746072 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_85a3c76def59 (Metraipolis archive dc_85a3c76def59, sha256 d794902ea37748ca5a8f06c9f089b6838684e976ad93b628caf6c573d961ad46)
BibTeX
@misc{dc85a3c76def59,
  title = {A Novel Inactivated Vaccine Based on an Emerging PEDV GIIc Variant Provides Cross-Protection Against Heterologous GII Strains — Europe PMC PMID:41746072},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41746072},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_85a3c76def59; sha256 d794902ea37748ca5a8f06c9f089b6838684e976ad93b628caf6c573d961ad46},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41746072. Agents can read the archived copy with the MCP tool read_document.